You have 9 free searches left this month | for more free features.

Condition

Acute Liver Failure (1)

Cirrhosis (1)

Fatty Liver (1)

Overall Status

Completed (2)

Phase

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

University of Texas Southwestern Medical Center (1)

Virginia Commonwealth University (1)

Collaborator

Medical University of South Carolina (1)

Meridian Bioscience, Inc. (1)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Oridion (1)

University of Michigan (1)

Intervention

13c-methacetin (2)

breath id machine (1)

Study Documents

Intervention Type

drug (2)

device (1)

Funder Type

Other (2)

Study Type

Interventional (2)

13c-methacetin

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Liver Failure Trial in United States (13C-Methacetin)

Completed

Has Results

Acute Liver Failure

13C-Methacetin

Birmingham, Alabama
+10 more

Nov 30, 2020

Fatty Liver, Cirrhosis Trial in Richmond (13C-Methacetin, Breath ID Machine)

Completed

Fatty Liver
Cirrhosis

13C-Methacetin
Breath ID Machine

Richmond, Virginia

Virginia Commonwealth University

Mar 16, 2017